In Response

Affiliations

¹ Department of Oncology, Hadassah and Hebrew University Medical Center, Jerusalem, Israel. Electronic address: nisman@hadassah.org.il.
² Neuroendocrine Tumor Unit, ENETS Centre of Excellence, Endocrinology & Metabolism Department, Hadassah Medical Organization, Jerusalem, Israel.
³ Department of Oncology, Hadassah and Hebrew University Medical Center, Jerusalem, Israel.
⁴ Department of Pathology, Hadassah Medical Organization, Jerusalem, Israel; Facullty of Medicine, The Hebrew University, Jerusalem, Israel.
⁵ The Institute of Oncology, Shaarei Zedek Medical Center, Jerusalem, Israel.
⁶ Neuroendocrine Tumor Unit, ENETS Centre of Exellence, Endocrinology & Metabolism Department, Hadassah Medical Organization, Jerusalem, Israel.
⁷ Department of Oncology, Hadassah and Hebrew University Medical Center, Jerusalem, Israel; Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
⁸ The Legacy Heritage Oncology Center, Soroka University Medical Center, Beer-Sheva, Israel; Faculty of Medicine, Ben Gurion University of the Negev, Beer-Sheva, Israel.
⁹ Neuroendocrine Tumor Unit, ENETS Centre of Excellence, Endocrinology & Metabolism Department, Hadassah Medical Organization, Jerusalem, Israel; Faculty of Medicine, The Hebrew University, Jerusalem, Israel.

Free article

Comment

Benjamin Nisman et al. J Thorac Oncol. 2023 Nov.

Free article

. 2023 Nov;18(11):e139-e141.

doi: 10.1016/j.jtho.2023.08.032.

¹ Department of Oncology, Hadassah and Hebrew University Medical Center, Jerusalem, Israel. Electronic address: nisman@hadassah.org.il.
² Neuroendocrine Tumor Unit, ENETS Centre of Excellence, Endocrinology & Metabolism Department, Hadassah Medical Organization, Jerusalem, Israel.
³ Department of Oncology, Hadassah and Hebrew University Medical Center, Jerusalem, Israel.
⁴ Department of Pathology, Hadassah Medical Organization, Jerusalem, Israel; Facullty of Medicine, The Hebrew University, Jerusalem, Israel.
⁵ The Institute of Oncology, Shaarei Zedek Medical Center, Jerusalem, Israel.
⁶ Neuroendocrine Tumor Unit, ENETS Centre of Exellence, Endocrinology & Metabolism Department, Hadassah Medical Organization, Jerusalem, Israel.
⁷ Department of Oncology, Hadassah and Hebrew University Medical Center, Jerusalem, Israel; Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
⁸ The Legacy Heritage Oncology Center, Soroka University Medical Center, Beer-Sheva, Israel; Faculty of Medicine, Ben Gurion University of the Negev, Beer-Sheva, Israel.
⁹ Neuroendocrine Tumor Unit, ENETS Centre of Excellence, Endocrinology & Metabolism Department, Hadassah Medical Organization, Jerusalem, Israel; Faculty of Medicine, The Hebrew University, Jerusalem, Israel.

No abstract available

Comment on

Comment on "Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report".
Qiu Z, Huang H, Zhang Y, Chen D. Qiu Z, et al. J Thorac Oncol. 2023 Nov;18(11):e138-e139. doi: 10.1016/j.jtho.2023.07.015. J Thorac Oncol. 2023. PMID: 37879774 No abstract available.